{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670319904558080.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1517/17425255.1.1.9"}},{"identifier":{"@type":"URI","@value":"http://www.tandfonline.com/doi/pdf/10.1517/17425255.1.1.9"}}],"dc:title":[{"@value":"Role of the aryl hydrocarbon receptor in drug metabolism"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670319904558082","@type":"Researcher","foaf:name":[{"@value":"Preeti Ramadoss"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319904558081","@type":"Researcher","foaf:name":[{"@value":"Craig Marcus"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670319904558080","@type":"Researcher","foaf:name":[{"@value":"Gary H Perdew"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"17425255"},{"@type":"EISSN","@value":"17447607"}],"prism:publicationName":[{"@value":"Expert Opinion on Drug Metabolism & Toxicology"}],"dc:publisher":[{"@value":"Informa UK Limited"}],"prism:publicationDate":"2005-06","prism:volume":"1","prism:number":"1","prism:startingPage":"9","prism:endingPage":"21"},"reviewed":"false","url":[{"@id":"http://www.tandfonline.com/doi/pdf/10.1517/17425255.1.1.9"}],"createdAt":"2005-06-14","modifiedAt":"2024-01-26","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360002217145827328","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232427375232","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Significance of A-to-I RNA editing of transcripts modulating pharmacokinetics and pharmacodynamics"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004232519577088","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Aryl hydrocarbon receptor nuclear translocator in human liver is regulated by miR-24"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168807277824","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Genome wide study of tardive dyskinesia in schizophrenia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021389817809920","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Exposure to Benzo[a]pyrene Decreases Noradrenergic and Serotonergic Axons in Hippocampus of Mouse Brain"}]},{"@id":"https://cir.nii.ac.jp/crid/1360022305562610944","@type":"Article","resourceType":"preprint","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Genome Wide Study of Tardive Dyskinesia in Schizophrenia"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285709266134144","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Current knowledge of microRNA-mediated regulation of drug metabolism in humans"}]},{"@id":"https://cir.nii.ac.jp/crid/1360286990853021696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Non-nucleoside hepatitis B virus polymerase inhibitors identified by an in vitro polymerase elongation assay"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617851455232","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"An introduction to EpiPol (Epigenetic affecting Polymorphism) concept with an in silico identification of CpG-affecting SNPs in the upstream regulatory sequences of human AHR gene"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657310642432","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Dioxin suppresses benzo[a]pyrene-induced mutations and DNA adduct formation through cytochrome P450 1A1 induction and (±)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide inactivation in human hepatoma cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593777374592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Adenosine-to-Inosine RNA Editing and N6-Methyladenosine Modification Modulating Expression of Drug Metabolizing Enzymes"}]},{"@id":"https://cir.nii.ac.jp/crid/2050025942007636736","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Modulation of benzo[a]pyrene–DNA adduct formation by CYP1 inducer and inhibitor"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1517/17425255.1.1.9"},{"@type":"CROSSREF","@value":"10.1074/jbc.m115.699363_references_DOI_NSt9Hac8scQFTRRQuywQYZOn1Cj"},{"@type":"CROSSREF","@value":"10.1038/s41398-021-01471-y_references_DOI_NSt9Hac8scQFTRRQuywQYZOn1Cj"},{"@type":"CROSSREF","@value":"10.1124/dmd.121.000390_references_DOI_NSt9Hac8scQFTRRQuywQYZOn1Cj"},{"@type":"CROSSREF","@value":"10.3390/ijms24129895_references_DOI_NSt9Hac8scQFTRRQuywQYZOn1Cj"},{"@type":"CROSSREF","@value":"10.1101/386227_references_DOI_NSt9Hac8scQFTRRQuywQYZOn1Cj"},{"@type":"CROSSREF","@value":"10.1080/17425255.2018.1472237_references_DOI_NSt9Hac8scQFTRRQuywQYZOn1Cj"},{"@type":"CROSSREF","@value":"10.1007/s00535-019-01643-0_references_DOI_NSt9Hac8scQFTRRQuywQYZOn1Cj"},{"@type":"CROSSREF","@value":"10.1016/j.mgene.2020.100805_references_DOI_NSt9Hac8scQFTRRQuywQYZOn1Cj"},{"@type":"CROSSREF","@value":"10.1186/s41021-017-0076-x_references_DOI_NSt9Hac8scQFTRRQuywQYZOn1Cj"},{"@type":"CROSSREF","@value":"10.1016/j.pharmthera.2017.07.003_references_DOI_NSt9Hac8scQFTRRQuywQYZOn1Cj"},{"@type":"CROSSREF","@value":"10.1016/j.taap.2012.02.012_references_DOI_NSt9Hac8scQFTRRQuywQYZOn1Cj"},{"@type":"CROSSREF","@value":"10.1016/j.mrgentox.2012.09.008_references_DOI_NSt9Hac8scQFTRRQuywQYZOn1Cj"}]}